Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's Arteritis

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's Arteritis	Aortic Arch Syndromes, Skin and Connective Tissue Diseases, Takayasu arteritis, aortic disorder, arteritis, cardiovascular disorder, skin disorder, skin vascular disease, vascular disorder, vasculitis	Not yet recruiting	Phase 4	2026-03-05		NCT07451665

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chinese SLE Treatment And Research Group	13

20 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beijing Anzhen Hospital Capital Medical University	Beijing	China	1
Jiangsu Province Hospital	Nanjing	China	37
Jiaozuo People's Hospital	Jiaozuo	China	1
Peking Union Medical College Hospital	Beijing	China	48
People's Hospital of Guangxi Zhuang Autonomous Region	Nanning	China	1
People's Hospital of Ningxia Hui Autonomous Region	Yinchuan	China	2
People's Hospital of Xinjiang Uygur Autonomous Region	Ürümqi	China	3
Shenzhen People's Hospital	Shenzhen	China	25
Sichuan Provincial People's Hospital	Chengdu	China	36
The Affiliated Hospital of Inner Mongolia Medical University	Hohhot	China	1
The First Affiliated Hospital of Baotou Medical College	Baotou	China	2
The First Affiliated Hospital of Henan University of Science and Technology	Luoyang	China	28
The First Affiliated Hospital of Sun Yat-sen University	Guanzhou	China	3
The First Hospital of China Medical University	Shenyang	China	42
The First Hospital of Jilin University	Ch’ang-ch’un	China	2
The First Hospital of Xinjiang Medical University	Ürümqi	China	1
The Second Affiliated Hospital of Nanchang University	Nanchang	China	32
the Second Affiliated Hospital of Zhejiang University School of Medicine	Hangzhou	China	29
Union Hospital Tongji Medical College of Huazhong University of Science and Technology	Wuhan	China	1
Xuanwu Hospital Capital Medical University	Beijing	China	6

Clinical trials